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Background: While the application of fetal MRI in high-risk pregnant women is steadily rising, little is known about
the psychological consequences of this procedure. The aim of the present study was to investigate emotional and
psychophysiological reactions of females undergoing fetal MRI.
Methods: Sixty women (17–44 ys), assigned for fetal MRI, were included. Affective state was assessed by
standardized measures of anxiety, emotional states and depressive symptoms. Stress coping strategies were
assessed using a self-report questionnaire. Stress responses were determined using skin conductance levels (SCL)
during fetal MRI as well as measurement of salivary cortisol levels immediately before and after fetal MRI.
Results: Analysis of fast and slow physiological stress measures revealed significant differences between women
with and without a supporting person accompanying them to the examination. For SCLs, lower levels of stress
during MRI emerged in accompanied women. Women with well-marked stress-coping-strategies experienced lower
levels of stress during the examination. Although fast and slow stress measures before and after MRI did not show
significant correlations, a significant difference of SCLs pre and post examination was clearly detectable, as well
as a trend of decreased cortisol levels for both time points.
Conclusions: The results imply that the elevation of SCLs is an accurate instrument to assess fast stress alterations
in patients during fetal MRI. Stress coping strategies and whether women are accompanied or not play an
important role in the experience of anxiety and depressive symptoms. These factors should be considered
especially in patients with high-risk-pregnancies to improve patient care.
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Fetal magnetic resonance imaging (MRI) is increasingly
used in prenatal diagnosis and can provide additional
information superior to routine ultrasonography [1,2].
Pregnant women undergoing MRI exams often receive
general information on the procedure, however have lim-
ited understanding of what to expect during the examin-
ation [3]. Hence, this implementation of highly developed
prenatal diagnostic methods may cause insecurity, stress,
and anxiety in pregnant women [4,5]. Previous studies* Correspondence: veronika.schoepf@uni-graz.at
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unless otherwise stated.have shown that anxiety and insecurity are influenced by
the state of pre-information and the patient’s experi-
ences of the MRI examination. Particularly sufficient
pre-information regarding the examination procedure
and the expecting experiences given by physicians are of
great importance and may help to ease the women’s anx-
iety for MRI exams [4,6].
Stress reactions are normally evoked in uncontrollable
and unpredictable situations and physical reactions ac-
companying these reactions, such as increased heart rate
or a higher level of vigilance, are part of an automated
response providing assistance in managing extreme and
demanding situations (for review see [7]). Threatening
or more demanding stressful situations can eventuallyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Descriptive information on how mothers were






No Count 8 4 12
% of total number 13.3% 6.7% 20.0%
Yes Count 23 25 48
% of total number 38.3% 41.7% 80.0%
Total Count 31 29 60
% of total number 51.7% 48.3% 100.0%
Regardless of the information status, mothers received information on the
procedure by a medical professional immediately before the scanning session.
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interactive (e.g., [8,9]). The physiological bases of any
stress response are the hypothalamic-pituitary-adrenal
(HPA) axis and the sympathetic adrenomedullary sys-
tem (SAM), which is part of the autonomic nervous
system (ANS).
A permanently increased stress response is considered
to be a potential risk factor for coronary heart diseases
specifically in males [10,11], while in females chronic
stress rather leads to depression and anxiety [12,13].
One group with potentially high stress reactions are
women with high-risk pregnancies [4]. In this group,
stress responses not only affect emotional well-being of
the patients but also interact with the progression of
stress-related physiological responses, probably inducing
long-term effects on the offspring’s postnatal develop-
ment. Maternal stress hormones carry information about
the external world, helping the fetus to prepare for the
environmental situation after birth [14]. Thus, the ma-
ternal stress hormone concentration provides signifi-
cant information to the offspring. However, chronic stress
during pregnancy should be avoided, as it is considered to
negatively influence the fetal development. Maternal pre-
natal stress has been associated with low birth weight [15],
preterm birth [16,17], cognitive development [18,19] as
well as mental or behavioral disorders such as schizophre-
nia [20] or attention deficit hyperactivity disorder [21].
The aim of the present study was to assess the psycho-
physiological and emotional reactions of women with
high-risk pregnancies undergoing an MRI examination.
We particularly focused on the stress level before, during
and after the MRI examination, which was assessed using
two different methods: salivary cortisol and skin conduct-
ance levels (SCL). Salivary cortisol levels represent stress
reactions activating the HPA axis, whereas skin conduct-
ance is a measure of the activation of the ANS. Addition-
ally, behavioral data regarding depressive symptoms, state
and trait anxiety, mood states, and stress coping strategies
were collected. Previous studies have shown that MRI
examinations in pregnant women are perceived as a very
stressful situation by the mothers (cf. [4]). Thus, a particu-
lar aim of this study was the investigation of psycho-
physiological parameters that might give insight in how
these female patients react to and cope with this situation,
thereby helping to reduce the stress experience and anx-




Sixty-three pregnant women who were referred from dif-
ferent gynecological practices situated in and around
Vienna as well as from the Department of Gynecology
of the Medical University of Vienna, Austria, underwentfetal MRI at the Department of Biomedical Imaging and
Image-guided Therapy, Medical University of Vienna.
Three subjects had to be excluded due to an early drop
out. Therefore, data from 60 females between the age of
17 and 44 years (mean 29.97; SD 6.3) and gestational
week 16 to 37 (mean 26.52; SD 4.7) at the time of fetal
MRI were included. None of the females reported having
suffered from neurological, psychiatric or psychosomatic
diagnoses and none was taking medication. Additionally,
we assessed how referred mothers were informed about
the fetal MRI examination (for more information see
Table 1). Five females out of the 63 mothers have already
had a fetal MRI examination due to a previous pregnancy.
Ethics statement
All participants were informed about the aim of the
study and gave their written informed consent prior to
inclusion. The study was performed in accordance with
the Declaration of Helsinki (1964), including current
revisions and the EC-GCP guidelines and was approved
by the Ethics Committee of the Medical University of
Vienna (026/2006).
Data acquisition
All measurements were performed on a 1.5 T system (Philips
Gyroscan, Philips, Best, The Netherlands) using a five-
channel phased-array surface coil. Imaging included the
following sequences: steady-state free-precession (SSFP)
surveys, reference scans, T2-weighted TSE sequences,
T1-weighted sequences, SSFP and dynamic SSFP sequences,
echo planar sequences (EPI), diffusion weighted imaging
(DWI), diffusion tensor imaging (DTI), fluid attenuated
inversion recovery (FLAIR) sequences, and single voxel
spectroscopy. Mean duration of examination did not ex-
ceed 45 minutes [22].
Subjects were classified due to the severity of previous
ultrasound using three different categories: no fetal malfor-
mation (group 1), fetal pathology compatible with survival
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with survival (group 3) [6] (group 1: 10 subjects, no fetal
malformation; group 2: 35 patients in total, mildly enlarged
ventricles (no identifiable cause, n = 9), enlarged cisterna
magna (no identifiable cause, n = 2), mild IUGR (n = 5),
skeletal pathologies (cleft lift and palate (n = 4), clubfood
(n = 1), micorcephaly (n = 1)), unilateral kidney pathologies
(hydronephrosis (n = 4), multicystic kidney (n = 1), dia-
phragmal hernia (contralateral lung volume normal, n = 2),
CCAM (n = 2), gastroschisis (n = 2), partial CCA (n = 1),
polyhydramnios (no identifiable cause, n = 1); group 3: 15
patients in total, large menigomyelocele (n = 1), complex
congenital heart defects (n = 6), stillbirths (n = 4), large
fetal tumors (n = 2), massive hydrocephalus (n = 1), large
spina bifida (n = 1)).
Saliva samples were collected before and after the MRI
examination for cortisol measurements. Skin conduct-
ance levels were monitored and recorded during the
MRI session using a non-polarizing MR compatible elec-
trode (see Figure 1). The electrode was placed on the
second finger of the non-dominant hand of the subject
using adhesive tape. An eight meter twisted pair cable
was used to connect the electrode with the recording unit
outside the scanner room. The SCL measurement de-
vices were manufactured in cooperation with the Center
for Medical Physics and Biomedical Engineering of the
Medical University Vienna.
Mood states were tested using PANAS scales [23] and
self-ratings of fear were assessed before and after the
MRI examination. Moreover, after completing the MRI
examination and assessment of socio-demographic andFigure 1 Non-polarizing MR compatible electrode with an eight mete
subjects while lying in the scanner.pregnancy-related data, all subjects underwent neuro-
psychological testing, including questionnaires tapping anx-
iety (State-Trait-Anxietyinventory STAI; Laux et al., [24]),
depressive symptoms (Beck Depression Inventory-II, BDI-II
[25]), and stress coping strategies (Stressverarbeitungsfragebogen,
SVF 120; [26]). A schematic visualization of the data ac-
quisition process can be found in Figure 2.
Data analysis
All participants arrived between 7 and 9 am. We ob-
tained two saliva samples, the first immediately before
and the second immediately after fetal MRI. Cortisol
samples were analyzed at the SwissHealthMed labora-
tory (Aying, Munich, Germany). Upon arrival of the
samples in the analysis laboratory the samples were fro-
zen at −20°C at least overnight. To precipitate mucins,
samples were thawed and centrifuged at 3000–2000 × g
for 10 min. Competitive Luminescence Immunoassay
kits (LUMI) were used to measure concentration of cor-
tisol (pg/ml). The LUMI kit is based on the competition
principle. These kits have minimal cross-reactivity to
other steroid hormones. Measurements were highly reli-
able (intra-assay CV < 4% and inter-assay CV < 5%). The
lower limit of sensitivity of the immunoassay kit was
0.003 μg/dL for cortisol.
Skin conductance time course measures were proc-
essed using Matlab 7.8.0 (R2000a). Analysis included time
course characteristic calculation of mean difference of the
first and last five minutes.
Statistical analyses were performed using the Statistical
Package for the Social Sciences, Version 20.0 (SPSS,r twisted pair cable used for recording skin conductance levels of
Figure 2 Graphic representation of the experimental design for all subjects. Measurements for each subject took place on the same day
(between 7 and 9 am) and included three different subprocedures. Immediately before fetal MRI (1) patients were informed about the whole
experiment, gave their written informed consent and completed two questionnaires. Subsequently saliva samples were taken. During fetal MRI
(2) skin conductance levels were monitored and recorded. Immediately after fetal MRI (3) saliva samples were taken, and several questionnaires
were completed.
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p = 0.05. For significant effects partial eta-squared (ηp
2)
are listed as estimates of effect size.
Results
Due to technical matters (broken finger electrode) SCL
measures were acquired from 37 females. Moreover, due
to insufficient amount of saliva, complete saliva samples
for cortisol analyses were collected from 58 females.
Saliva and SCL measures from two females had to be
excluded due to nausea during the MRI examination.
No significant correlation was obtained for SCL and
cortisol levels (r = −0.018; p = 0.922). Subjects showed sig-
nificant higher cortisol levels immediately before fetal
MRI examination (t = 4.215, p < .001), as well as significant
higher skin conductance levels during the first five mi-
nutes in the MR scanner (t = 2.733, p = 0.010 (see
Table 2)).
Correlation analysis revealed a significant association
of age with depressive scores of participants and cortisol
levels measured after fetal MRI scan (see Table 3).Table 2 Description of cortisol levels immediately before
(t1) and after (t2) fetal MRI examination and for skin
conductance levels of the first 5 minutes (t1) and last
5 minutes (t2)
N Mean SD
Cortisol t1 (pg/ml) 56 6415.36 2974.14
Cortisol t2 (pg/ml) 56 5182.32 2169.01
SCL t1 (μs) 35 29644.14 12786.42
SCL t2 (μs) 35 25369.11 12627.83
Mean values and standard deviation for cortisol levels, as well as for SCL measures,
and number of subjects are included. Cortisol levels (t = 4.215, p < .001) and SCL
values (t = 2.733, p = .010) differed significantly between t1 and t2.Based on these results the impact of accompanying
person, diagnosis and stress management strategies (for
further group description see Table 4) were analyzed on
cortisol levels, SCL measures, and psychological parame-
ters (mood, depression, anxiety). Results are reported
separately in the following paragraphs.Accompanying person
We divided our participants into accompanied (n = 35)
or non-accompanied (n = 25) females. Groups neither dif-
fered in age (p = 0.363) nor gestational week (p = 0.996) or
diagnosis (p = 0.096; see also Table 4).Cortisol
Due to significant influence of the variable age (r = −0.274;
p = 0.037), changes in cortisol levels were analyzed using
an analysis of covariance for repeated measurements with
the within-subject factor time (pre and post MRI) and the
between-subject factor group (with or without accom-
panying person). Analysis revealed no significant main
effect of time (F(1,53) = 0.522, p = 0.473), no significant
group effect (F(1,53) = 0.629, p = 0.431), and no significant
time-by-group interaction for cortisol levels (F(1,53) =
0.710, p = 0.403) emerged (see Figure 3a).Table 3 Representation of detected significant correlations
Correlation coefficient (r) Significance (p)
Depressive score (BDI) 0.292 0.024
Cortisol (t2) −0.274 0.037
Correlation analysis revealed significant results for SCL-differences, depressive score
(BDI) and cortisol (t2) and confounder variables gestational week and age.
Table 4 Different categorizations of all 60 subjects were performed ahead of statistical analysis
Groups N Age (mean) GW (mean)
Accompanying person
Yes 35 30.8 26.5
No 25 29.3 26.5
Prenatal Diagnosis
No fetal malformation (1) 10 35.3** 25.2
Fetal pathology compatible with survival (2) 35 29.1 27.0
Fetal pathology probably not compatible with survival (3) 15 28.4 26.3
Stress-regulation-strategy
Below average strategies 11 29.3 26.0
Average strategies 30 30.2 26.5
Above average strategies 19 30.0 26.9
An overview of these three groups and inherent subgroups is given in this table indicating number of subjects (N), mean age and mean gestational week (GW).
For the variable accompanying person groups neither differed in age (p = 0.363) nor gestational week (p = 0.996) or diagnosis. Analysis for prenatal diagnosis
revealed no difference in gestational week (F(2,57) = 0.573, p = 0.567); but patients in group 1 were significantly older compared to both other groups, (1 vs. 2:
p = 0.008; 1 vs. 3: p = 0.001), while group 2 and 3 did not differ (p = 0.703). For stress-regulation strategy groups neither differed in age (F(2,57) = 0.129, p = 0.879)
nor gestational week (F(2,57) = 0.083, p = 0.920). Significant differences are marked in the table with **.
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Repeated measurements analysis of variance (rmANOVA)
with the within-group factor time (t1, t2) and between-
subjects factor group (with or without accompanying
person) revealed a significant time effect (F(1, 33) = 6.798,
p = 0.014, ηp
2 = 0.171) with higher values at t1, no sig-
nificant group effect (F(1, 33) = 0.467, p = 0.499) but a
significant time-by-group interaction (F(1, 33) = 11.294,
p = 0.002; ηp
2 = 0.255) (see Figure 3b). Post-hoc analysis
of the significant interaction showed a significant decrease
in SCL values from t1 to t2 only in the accompanied
group (t = 4.212, p < 0.001), whereas no such difference
was obtained in the non-accompanied group (t = −0.569,
p = 0.579). Moreover, groups did not differ in their t1
values (p = 0.675) neither in their t2 values (p = 0.085).
Mood
Changes in mood were analyzed using a rmANOVA with
the within-subject factor time (pre and post MRI) and the
between-subjects factor group (with or without accom-
panying person). For positive affect (PA, F(1,58) = 23.702,
p < 0.001, (ηp
2 = 0.290)) as well as for negative affect (NA,
F(1,58) = 10.616, p = 0.002, (ηp
2 = 0.155)) a main effect of
time was revealed (see Figure 4). No significant group effect
(PA: F(1,58) = 0.315, p = 0.577; NA: F(1,58) = 1.331, p =
0.253) and no time-by-group interaction (PA: F(1,58) =
0.941, p = 0.336; NA: F(1,58) = 0.821, p = 0.369) emerged.
Regarding the self rating of fear, a rmANOVA with
time (t1, t2) and group as factors showed no significant
time effect (F(1,58) = 2.815, p = 0.099), no significant
group effect (F(1,58) = 0.311, p = 0.579) but a marginally
significant time-by-group interaction (F(1,58) = 3.916,
p = 0.053, ηp
2 = 0.063). Explorative post-hoc analysis
showed that only in the accompanied group a significantreduction in fear ratings was apparent (p = 0.006), while
no such decrease occurred in the non-accompanied group
(p = 0.852).
Analysis of covariance including age as covariate
(r = −0.292; p = 0.024) with group (with or without ac-
companying person) as fixed factor revealed no significant
effect for depressive symptoms (BDI, F(2,57) = 2.795, p =
0.069) as well as for multivariate analysis of variance for
state-anxiety (STAI, F(1,58) = 0.444, p = 0.508) or trait-
anxiety (STAI, F(1,58) = 0.006, p = 0.939).
Diagnoses
According to the diagnosis participants were divided
into suspected but not confirmed fetal malformation on
ultrasound (group 1, n = 10), fetal pathology compatible
with survival (group 2, n = 35) and fetal pathology prob-
ably not compatible with survival (group 3, n = 15).
Groups did not differ in gestational week (F(2,57) =
0.573, p = 0.567) but we observed a significant group dif-
ference in age (F(2,57) = 5.095, p = 0.009) with group 1
being significantly older than both other groups (1 vs. 2:
p = 0.008; 1 vs. 3: p = 0.001), while group 2 and 3 did not
differ (p = 0.703). See Table 4 for details.
Cortisol
Analysis of covariance (including age) for repeated mea-
surements with the within-subject factor time (pre and
post MRI) and the between-subject factor diagnosis
(groups 1, 2, 3) revealed no main effect of time (F(1,52) =
0.641, p = 0.427) as well as no significant diagnosis ef-
fect (F(2,52) = 0.835, p = 0.440). Moreover, no time-by-
diagnosis interaction between severity of diagnosis on
cortisol measures was obtained (F(2,52) = 1.571, p = 0.218)
(see Figure 5a).
Figure 3 Stress measures cortisol and skin conductance
measures before and after fetal MRI depending on
accompanying person. a) All subjects showed higher cortisol levels
before compared to post examination. b) Skin conductance levels
(SCL, in μs) of the first 5 minutes (t1) and last 5 minutes (t2) of fetal
MRI examination of women with (yes) and without (no) support by
an accompanying person. Accompanied women showed a
significant reduction of SCL-levels at the last 5 minutes of
the examination.
Figure 4 Mean scores of positive and negative affect scale
showing higher positive as well as negative scores immediately
before compared to post fetal MRI examination for all subjects.
Significant differences are marked with an asterisk.
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RmANOVA with time as within-subject factor (t1, t2)
and diagnosis as between-subjects factor (groups 1, 2, 3)
revealed a significant time effect (F(1, 32) = 8.463, p =
0.007, ηp
2 = 0.209) indicating lower levels at t2, no sig-
nificant effect of diagnosis (F(2, 32) = 0.521, p = 0.599) ortime-by-diagnosis interaction (F(2, 32) = 1.013, p = 0.375)
(see Figure 5b).
Mood
Analysis of variance for repeated measurements with the
within-subject factor time (pre and post MRI) and the
between-subjects factor diagnosis revealed a signifi-
cant effect of time for positive (PA, F(1,57) = 18.549,
p < 0.001, ηp
2 = 0.246) as well as for negative (NA, F(1,57) =
9.207, p = 0.004, ηp
2 = 0.139) mood, with significantly lower
positive and lower negative mood after MRI. However, no
significant diagnosis effect (PA: F(2,57) = 0.126, p = 0.882;
NA: F(2,57) = 0.357, p = 0.701) and no time-by-diagnosis
interaction (PA: F(2,57) = 0.185, p = 0.832; NA: F(2,57) =
0.125; p = 0.883) emerged.
Regarding the self-rating of fear, no significant time ef-
fect (F(1,57) = 2.738, p = 0.104), no significant diagnosis
effect (F(1,57) = 0.024, p = 0.976) and no significant time-
by-diagnosis interaction (F(1,57) = 0.842, p = 0.436) emerged.
Multivariate analysis of variance with diagnosis as
fixed factor revealed no main effect of severity of diag-
nosis for state anxiety (F(2,57) = 0.308, p = 0.736) or trait
anxiety (F(2,57) = 0.754, p = 0.475). Moreover, no signifi-
cant effect of diagnosis on depression scores (F(3,56) =
2.395, p = 0.078) was obtained.
Stress regulation and coping strategies
Using the positive strategies (POS) of the SVF 120, fe-
males were distributed into three groups of stress coping
strategies based on their percentile ranks: below average
Figure 5 Stress measures cortisol and skin conductance
measures before and after fetal MRI depending on severity of
diagnosis. a) Cortisol levels immediately before (pre) and after
(post) fetal MRI examination for women grouped by severity of
diagnosis. All cortisol levels were reduced after MRI examination,
with the best effect for the subgroup in which the fetal pathology
was probably not compatible with survival. b) Skin conductance
levels (SCL, in μs) of the first 5 minutes (t1) and last 5 minutes (t2) of
fetal MRI examination of women grouped by severity of diagnosis.
All SCL levels were reduced after MRI examination, with the best
effect for the subgroup with no fetal malformation.
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average (PR = 76-100, n = 19) usage. Groups neither dif-
fered in age (F(2,57) = 0.129, p = 0.879) nor gestational
week (F(2,57) = 0.083, p = 0.920). See also Table 4 fordetails. Due to fewer data sets of SCL-measurements and
subsequent distribution of subjects, only two groups were
built for SCL-levels: average (PR = 25-75) and above aver-
age (PR = 76-100).
Cortisol
Regarding cortisol levels, rmANCOVA with age as covari-
ate and time as well as strategy group as factors revealed
no significant time effect (F(1,48) = 0.003, p = 0.955), no
significant strategy group effect (F(2,48) = 1.402, p = 0.256)
and no significant time-by-group interaction (F(2,48) =
0.094, p = 0.910).
SCL
RmANOVA with time as within-subject factor and strat-
egy group as between-subjects factor revealed a signifi-
cant time effect (F(1, 26) = 7.496, p = 0.011, ηp
2 = 0.224)
but no significant group effect (F(1, 26) = 0.001, p = 0.972),
and no significant time-by-group interaction (F(1, 26) =
2.265, p = 0.144) (see Figure 6b).
Regarding emotional states a multivariate analysis of
variance with group as fixed factor showed no significant
differences concerning positive (PA; F(2,57) = 1.310, p =
0.278) and negative (NA; F(2,57) = 0.281, p = 0.756) mood.
Regarding the self-ratings of fear, neither a significant
time effect (F(1,57) = 2.688, p = 0.107), nor a significant
group effect (F(2,57) = 1.485, p = 0.235) or time-by-group
interaction (F(2,57) = 0.242, p = 0.786) emerged.
However, groups differed significantly in their BDI
scores (F(3,52) = 4.031, p = 0.023, ηp
2 = 0.124). Bonferroni
corrected post-hoc analysis showed a significant difference
between women with above-average (group 3) and women
with average stress coping strategies (group 2), obtaining
lower depressive symptoms in women with above-average
strategies (p = 0.038). All other comparisons remained not
significant (1 vs. 2: p = 1.000; 1 vs. 3: p = 0.081).
To determine the impact of stress coping strategies on
state- and trait-anxiety an analysis of variance with group
(below average, average and above average) as fixed factor
was performed. No significant influence of stress coping
strategies on state- (F(2,53) = 1.196, p = 0.311) or trait-
anxiety (F(2,53) = 2.083, p = 0.135) was obtained.
Discussion
This study set out to offer a more thorough look on the
emotional and physiological responses to fetal MRI in
pregnant women by investigating stress levels examining
three main factors, 1) accompanying person, 2) severity of
diagnosis, and 3) stress management strategies used by
the pregnant women.
Stress response: Cortisol vs. Skin conductance levels (SCL)
We decided to assess salivary cortisol levels and skin con-
ductance to measure different stress layers of response.
Figure 6 Stress measures cortisol and skin conductance
measures before and after fetal MRI depending on stress
management strategies. a) Cortisol levels immediately before (pre)
and after (post) fetal MRI examination for women grouped by
characteristics of their stress management strategies. All cortisol
levels were reduced after MRI examination. b) Skin conductance
levels (SCL, in μs) of the first 5 minutes (t1) and last 5 minutes (t2) of
fetal MRI examination of women grouped by characteristics of their
stress management strategies. Women with above average
strategies were able to relax the most during the MRI examination.
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and may therefore be referred to as the fast reacting path-
way, as activation of this system directly leads to the
release of catecholamines such as adrenalin and nor-
adrenalin. In further consequence this release is followed
by physical reactions like increase of heart rate, blood
pressure, and changes in electrodermal activity [27]. Com-
plementary to the SAM-system, the activation of the
HPA-axis represents the slower stress response reactionand leads to the secretion of cortisol. The peak level of
cortisol is reached approximately 21–40 minutes after the
onset of a stressor [7]. Due to that complementary rela-
tionship we included both, the fast as well as the slow
stress reaction response in our study.
Accompanying person
Thirty-five of our female participants were accompanied
by their partner, whereas 25 females were without partner
or any other relevant person. Data analysis showed that
for SCL values a significant group-by-time effect was ob-
servable indicating lower stress values in the last five mi-
nutes of MR scanning only in the accompanied group. In
the non-accompanied group SCL levels showed no signifi-
cant decrease over time but stayed relatively high through-
out the experiment. We speculate that this significant
decrease in women who know that someone personally
relevant was waiting next to the MR scanner in the same
room seems to have a comforting and positive effect on
the stress response. Interestingly for cortisol we did not
see such an interaction with group, only a time effect was
apparent, with lower cortisol after the MR measurement.
This was true for both groups.
Moreover, we also observed a significant effect of ac-
companying person on self-ratings of fear which were
significantly lower at the end of the MR exam only in
the accompanied group. Again, the single group did not
show a decrease in fear level.
The investigation of how accompaniment influences
psychological and physiological well-being is frequently
performed in children undergoing medical examinations
(e.g., [28,29]; for review). However, little is known on
how accompaniment influences stress responses in adults
undergoing a critical medical examination. In a previous
study by Leithner et al. [6], the investigated women sug-
gested to focus on the routine presence of the partner as
an improvement in the procedure of fetal MRI. These re-
sults are in line with our data since we found decreased
stress and fear levels in the accompanied group only.
Severity of diagnosis
According to the severity of fetal diagnosis we split our
sample into three groups: no fetal malformation but risk
(group 1, n = 10), fetal pathology compatible with survival
(group 2, n = 35) and fetal pathology probably not compat-
ible with survival (group 3, n = 15). Interestingly and
against our expectations, we did not see any significant
impact of severity of diagnosis on stress responses. All
three groups showed a decline in cortisol and a significant
decrease of SCL levels over time, but no group-specific
effect was detected. This was also true for mood and fear
ratings.
Notably, Leithner and colleagues [4] observed a signifi-
cant effect of severity of the referral diagnosis on anxiety
Derntl et al. BMC Pregnancy and Childbirth  (2015) 15:25 Page 9 of 10levels before MRI. Anxiety measures showed a linear in-
crease with pathology, indicating lowest anxiety in at-risk
females and highest anxiety levels in females diagnosed
with fetal malformation not compatible with survival.
Interestingly, after the MRI exam the authors reported
similar anxiety levels and thus a significant decline in all
three groups. As the authors themselves state, information
deficits about the procedure and the course of fetal MRI
particularly in women with poor fetal prognoses negatively
influence emotional and stress responses. In the present
sample, 80% of the investigated females reported that they
were intensively informed. Importantly, in the more severe
groups (fetal pathology compatible or not compatible with
survival) almost 90% of the females said they were in-
formed, only in the at-risk group 40% were not informed.
Thus, our findings support previous assumptions that in-
formation about the procedure and course of the medical
examination helps pregnant women to cope with the stress-
ful situation [30].
It would have been of great interest to compare mater-
nal stress response after confirmation or exclusion of the
fetal diagnosis after the MRI investigation. As patients
are informed about the diagnosis of the MRI examin-
ation not immediately after the procedure but by their
referring physician, this was not possible in the reported
study, but should be investigated in future studies.Stress regulation and coping
Based on their profile of using positive stress coping
strategies (POS) of the SVF 120, we distributed our sam-
ple to three groups: below average (PR = 0-24, n = 11),
average (PR = 25-75, n = 30) and above average (PR = 76-
100, n = 19) usage. Similar to the data on severity of
diagnosis, we only observed an effect of time, with lower
cortisol and significantly lower SCL levels after MRI
across all groups.
Interestingly, groups differed in their self-rating of de-
pressive symptoms, with the females with above-average
scores reporting significantly less depressive symptoms
than females with average coping strategies. Notably,
groups did not differ in percentage of informed vs. not
informed females or severity of diagnosis – both factors
were distributed evenly across the three stress manage-
ment groups. The experience of stress can be altered
cognitively by relying on cognitive regulation strategies
in order to decrease or down-regulate negative subject-
ive experiences [31-33]. Moreover, Leithner et al. [6] re-
ported that in their study, the investigated females tried
to down-regulate their distress and fear by distraction or
by thinking “agreeable thoughts”. Being able to down-
regulate ones sensations and feelings might not only be
a positive option for patients undergoing critical medical
exams but also before in order to decrease depressivesymptoms that might arise due to the medical situation
or the anticipation of the medical exam.
Conclusions
Taken together, SCL data and fear self-rating indicate a
significant positive effect of accompanying person on
stress and emotional reactions in pregnant women under-
going fetal MRI. Moreover, our data support previous
findings of a positive effect of information on the proced-
ure and course of fetal MRI on stress and emotional re-
sponses in high-risk pregnant females. And, introducing
or supporting emotion regulation strategies might help to
decrease depressive symptomatology in these patients and
thus might help to improve patient’s comfort.
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